Abstract
Aim: To evaluate short term safety of an enhanced photodynamic therapy (PDT) protocol with half dose verteporfin for treating chronic central serous chorioretinopathy (CSC). Methods: 20 eyes of 18 patients...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have